Cargando…
New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CRC of approximately 61.0%-91.0%, which drops to 27....
Autores principales: | Malagón, Marta, Ramió-Pujol, Sara, Serrano, Marta, Amoedo, Joan, Oliver, Lia, Bahí, Anna, Miquel-Cusachs, Josep Oriol, Ramirez, Manel, Queralt-Moles, Xavier, Gilabert, Pau, Saló, Joan, Guardiola, Jordi, Piñol, Virginia, Serra-Pagès, Mariona, Castells, Antoni, Aldeguer, Xavier, Garcia-Gil, L. Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707514/ https://www.ncbi.nlm.nih.gov/pubmed/33259546 http://dx.doi.org/10.1371/journal.pone.0243158 |
Ejemplares similares
-
Clinical performance study of a fecal bacterial signature test for colorectal cancer screening
por: Malagón, Marta, et al.
Publicado: (2023) -
A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples
por: Oliver, Lia, et al.
Publicado: (2021) -
Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019) -
Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996) -
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)